Clinical Trials

NEW YORK, March 07, 2017 — AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced enrollment of 40 patients and commencement of its Phase II clinical trial for the treatment of irritable bowel syndrome (IBS) with the company’s CanChew Plus® CBD gum. The study is being conducted by […]

My home state of Missouri has an opportunity to pass a medical marijuana bill this session, and a Republican is leading the fight. It is imperative to have a member of the GOP leading the way as the Show-Me State has gone from a “purple” swing state to a “deep red” Republican-controlled state in recent […]

Jason David administers cannabis oil in tincture form to his son, Jayden. Legislation allowing for low-THC, CBD-rich marijuana oil has been approved for limited use in 14 states. Cannabidiol (CBD) is one of the many chemicals in marijuana. Recent publicity about children who suffer from seizures benefitting from oil extracted from marijuana that has almost […]

© Stock Pot Images / Cindi Spears-Cahill The cannabis lifestyle is great for those who choose to consume, but is cannabis okay for your pet? When it comes to furry friends and THC – the answer is definitely no, it’s not safe to feed Fido any marijuana. Just because pet owners are already using cannabis […]

OTTAWA, ONTARIO–(Marketwired – Feb 23, 2017) – PhytoPain Pharma (PPP), a subsidiary of Tetra BioPharma Inc. (“Tetra” or the “Company“) (CSE:TBP)(TBP.CN)(OTC PINK:GRPOF), a pharmaceutical company focused on developing and commercializing therapeutic cannabis-based products for the treatment of pain is pleased to announce the launch of its Double-Blind Phase I Study to Assess Safety, Tolerability, Pharmacodynamics […]

In the early 1960s, though cannabis had been used for centuries and demonized for decades by governments around the globe, the science world knew surprisingly little about the plant itself. Scientists had long since learned how to synthesize morphine from the opium poppy and cocaine from coca leaves, but what about cannabis? Few in the […]

DEVON, Pa., March 01, 2017 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that Armando Anido, Chairman and Chief Executive Officer, will present at upcoming investor conferences in March, including: 29th Annual ROTH Conference in Orange County, CA, on […]

LONDON, Nov. 10, 2016 /PRNewswire/ — Bone marrow transplant or hematopoietic stem cell transplant is the surgical procedure to replace impaired bone marrow tissue or bone marrow stem cells with healthy ones. Bone marrow transplant procedure is recommended to treat severe stages of leukemia, Hodgkin and non-Hodgkin lymphomas, multiple myeloma, aplastic and sickle cell anemia, […]

DEVON, Pa., March 01, 2017 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that Armando Anido, Chairman and Chief Executive Officer, will present at upcoming investor conferences in March, including: 29th Annual ROTH Conference in Orange County, CA, on […]

Shares of INSYS Therapeutics, Inc. (NASDAQ:INSY) dropped -6.02% by the end of trading session at $12.03. For the current quarter, the 4 brokerage firms issuing adjusted earnings per share outlook have a consensus forecast of 0/share, which would compare with $0.36 in the year-ago quarter. The net percentage change is -28.31% over the last 12 […]

by

OTTAWA, ONTARIO–(Marketwired – Feb 23, 2017) – PhytoPain Pharma (PPP), a subsidiary of Tetra BioPharma Inc. (“Tetra” or the “Company“) (CSE:TBP)(TBP.CN)(OTC PINK:GRPOF), a pharmaceutical company focused on developing and commercializing therapeutic cannabis-based products for the treatment of pain is pleased to announce the launch of its Double-Blind Phase I Study to Assess Safety, Tolerability, Pharmacodynamics […]

by

SAN DIEGO, Feb. 6, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment AXIM® Biotechnologies, Inc. (OTC: AXIM) was featured on a CBS New York News segment about the Company’s clinical trials for its CanChew Plus® cannabidiol (CBD) chewing gum for the […]

by